UTHSCSA Faculty Profiles v1.0
Qunibi, Wajeh Y
School of Medicine
Medicine
(210) 358-2962
qunibi@uthscsa.edu
|
|
| 9/2004 - Present |
Professor of Medicine |
University of Texas Health Science Center at San Antonio, Medicine, San Antonio, TX |
| 3/2001 - Present |
Medical Director |
University Hospital, Inpatient Hemodialylsis Unit, Inpatient Hemodialylsis Unit, San Antonio, TX |
| 6/1999 - Present |
Medical Director |
University Dialysis Northwest Unit, Dialysis Unit, San Antonio, TX |
| 6/1999 - Present |
Attending Nephrologist |
University Hospital, San Antonio, TX |
| Year |
Degree |
Discipline |
Institution |
| 1972 |
MD |
Medicine (with Honors) |
Alexandria University School of Medicine
Alexandria , Egypt |
| 1966 |
|
Science |
Alexandria University School of Medicine
Alexandria , Egypt |
| |
Internship |
Internal Medicine |
Union Memorial Hospital-Johns Hopkins Hospital
Baltimore , MD |
| |
Clinical Fellowship |
Nephrology |
Baylor College of Medicine
Houston , TX |
| |
Residency |
Internal Medicine |
Union Memorial Hospital-Johns Hopkins Hospital
Baltimore , MD |
Research Interest -
My research is focused on cardiovascular disease in patients with Chronic Kidney Disease. In particular, I have major interest in hyperphosphatemia of chronic kidney disease, renal osteodystrophy, vitamin D deficiency and cardiovascular calcification. I have also conducted studies on treatment of anemia of patients with chronic kidney disease with IV iron and ESA therapies. I have also been involved in recent clinical trials using ZS-9 for treatment of hyperkalemia. I have published book chapters and numerous articles, reviews and editorials. I also serve as a reviewer for several scientific journals including Journal of the American Society of Nephrology, Clinical Journal of the American Society of Nephrology, Kidney International, American Journal of Kidney Disease, Nephrology Dialysis Transplantation, Hemodialysis International, and BMC Nephrology. I have contributed 7 chapters in UpToDate. |
| Date |
Description |
Institution |
# Students |
| 9/2007 - Present |
Post-Doctoral Student Supervision |
University of Texas Health Science Center at San Antonio |
|
|
| 7/1999 - Present |
Lecture to Second Year Medical Students |
University of Texas Health Science Center at San Antonio |
|
| One, 2 hour lecture a year since 1999 |
| 7/1999 - Present |
Rotation Student Supervision |
University of Texas Health Science Center at San Antonio |
|
|
| 7/1999 - Present |
Post-Doctoral Student Supervision |
University of Texas Health Science Center at San Antonio |
|
|
Electronic/Web Publication |
| Qunibi WY. Prescribing and assessing adequate hemodialysis 2017 Jan. |
| Qunibi WY. Overview of Chronic Kidney disease-Mineral Bone Disorder (CKD-MBD) 2017 Jan. |
| Qunibi WY. Treatment of anemia in peritoneal dialysis patients 2017 Jan. |
| Qunibi WY. Aluminum toxicity in end-stage renal disease 2017 Jan. |
| Qunibi WY. Protein intake in maintenance hemodialysis patients 2017 Jan. |
Private |
| Funding Agency |
Nabi Pharmaceuticals |
| Title |
EPIC (Effect of PhosLo on Phosphorous Levels in Chronic Kidney Disease): A Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Arm, Study of Calcium Acetate (PhosLo) on Phosphorous Levels in Subjects with Stage 4 Chronic Kid |
| Status |
Active |
| Period |
7/2005 - Present |
| Role |
Principal Investigator |
| Grant Detail |
|
| Funding Agency |
Luitpold Pharmaceuticals, Inc. |
| Title |
Comparison of the Safety and Efficacy of a Unique Intravenous Iron Preparation (VIT-45) versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease |
| Status |
Active |
| Period |
11/2005 - Present |
| Role |
Principal Investigator |
| Grant Detail |
|
| Funding Agency |
ZS Pharma |
| Title |
Phase III multicenter, two-phase, multi-dose, prospective, randomized, double-blind, placebo-controlled study to investigate the safety and efficacy of ZS(Microporous, Fractionated, Protonated Zirconium Silicate), and oral sorbent, in subjects with mild |
| Status |
Active |
| Period |
4/2013 - Present |
| Role |
Principal Investigator |
| Grant Detail |
|
